Bristlecone Advisors’s Abiomed Inc ABMD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-2,153
| Closed | -$529K | – | 260 |
|
|
2022
Q3 | $529K | Buy |
2,153
+4
| +0.2% | +$983 | 0.07% | 159 |
|
|
2022
Q2 | $532K | Buy |
2,149
+312
| +17% | +$77.2K | 0.07% | 163 |
|
|
2022
Q1 | $608K | Buy |
1,837
+110
| +6% | +$36.4K | 0.07% | 146 |
|
|
2021
Q4 | $620K | Buy |
1,727
+282
| +20% | +$101K | 0.07% | 151 |
|
|
2021
Q3 | $470K | Buy |
1,445
+104
| +8% | +$33.8K | 0.06% | 156 |
|
|
2021
Q2 | $419K | Buy |
1,341
+14
| +1% | +$4.37K | 0.06% | 160 |
|
|
2021
Q1 | $423K | Buy |
1,327
+77
| +6% | +$24.5K | 0.06% | 152 |
|
|
2020
Q4 | $405K | Buy |
1,250
+149
| +14% | +$48.3K | 0.06% | 154 |
|
|
2020
Q3 | $305K | Buy |
+1,101
| New | +$305K | 0.06% | 152 |
|